Altogen Biosystems

PRODUCTS

CUSTOM SERVICES

CUSTOMER SUPPORT

CONTACT US

 

 

 

 

 
Focus Areas
Transfection Resource
How to Order
Technical Support

 

 

 

 

 

 

Keratinocyte Transfection Reagent

Catalog # 1783 - 0.5 mL        $ 126.00

Catalog # 1784 - 1.5 mL        $ 269.00

Transfection reagent for Keratinocyte cells

  • Kit includes Transfection Enhancer reagent and recommended transfection protocols
  • Protocols provided for transfection of microRNA and siRNA
  • High transfection efficiency
  • High cell viability
  • Compatible with transfection in any plate format
  • Reproducible transfection
  • Ideal for primary cells
  • Developed and manufactured by Altogen Biosystems
  • Transfection Efficiency:
    Reagent exhibits at least 85% transfection efficiency of siRNA delivery. Transfection efficiency was determined by real-time RT-PCR.

    Transfection Protocol:
    Transfection protocols are provided with the purchase of the reagent.

DATA

keratinocyte

Figure 1. Cyclophilin B silencing efficiency was determined by qRT-PCR in the cells transfected by Cyclophilin B siRNA or non-silencing siRNA control following the recommended transfection protocol. Cyclophilin mRNA expression levels were measured 48 hours post-transfection. 18S rRNA levels were used to normalize the Cyclophilin B data. Values are normalized to untreated sample. Data are presented as means ± SD (n=3).

Cancer Cell Lines and Primary Cells

Primary cell cultures are used in biological and gene therapy studies and serve as important model systems that may more accurately represent the biology of normal cells. Many cultured cell lines, as well as the majority of primary cell cultures are able to be transfected with exogenous nucleic acids when appropriate transfection approaches are employed. Since the majority of transfection methods causes significant toxicity in primary cell cultures, optimizing this procedure, specifically the protocol and reagents to be utilized, is essential for developing an effective transfection strategies for a given cell type. ALTOGENŽ Kits for primary cells and sensitive cell lines have been designed to have significantly lower cytotoxicity than classical alternatives.

Altogen Biosystems

Altogen Biosystems is a life sciences company dedicated to the development, marketing and manufacture of cell type specific transfection reagents. Efficient delivery of DNA, RNA, siRNA, and microRNA enabled by advanced formulation of reagents and peculiar design of protocols. Altogen Biosystems offers a complete transfection system for a broad range of cell lines. All reagents are functionally tested to be highly reproducible, serum compatible, induce low toxicity, and can be used for co-transfection experiments, and high throughput applications.

 

Copyright ©2006 Altogen Biosystems. All rights reserved.